Daré Bioscience, Inc.
DARE
$2.89
-$0.095-3.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.10% | -136.42% | 291.12% | -33.57% | 39.06% |
| Total Depreciation and Amortization | -34.02% | -37.01% | 42.59% | 8.00% | 7.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.20% | -7.41% | -48.22% | 390.02% | -167.57% |
| Change in Net Operating Assets | 621.21% | -151.57% | 49.16% | 43.19% | -537.38% |
| Cash from Operations | 188.23% | -145.91% | 289.41% | 16.70% | -2.57% |
| Capital Expenditure | -299.36% | 198.98% | -3,806.85% | 98.80% | -2,647.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -299.36% | 198.98% | -3,806.85% | 98.80% | -2,647.96% |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -50.00% | -86.83% | 66.67% | 0.00% | -50.00% |
| Issuance of Common Stock | -- | -100.00% | -14.92% | -72.63% | -90.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.00% | 50.00% | -14.29% | -100.01% | -- |
| Cash from Financing | -130.25% | 278.16% | 724.29% | -99.74% | -38.09% |
| Foreign Exchange rate Adjustments | -389.08% | 56.85% | 137.24% | -166.89% | 490.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.17% | -140.65% | 286.24% | -100.25% | -704.71% |